Zambon Biotech is part of the Zambon group, it is focused in growing the portfolio and pipeline of the Zambon group by entering into partnerships, acquiring assets and supporting their clinical development up to commercialization as well as licensing commercial stage assets.
Cooperation possibilities
Our strategic therapeutic areas are Central Nervous System, Severe Respiratory and Rare diseases.
We are currently looking to expand our product portfolio and pipeline with opportunities from phase IIa to registration.
- http://www.zambon.com
- cibele.sabido@zambongroup.com
- Cibele Sabido David, PhD
